@article{450200f98eba4f3ca22ef7ab925fb2e4,
title = "Uptake of the OMERACT-OARSI hip and knee osteoarthritis core outcome set: Review of randomized controlled trials from 1997 to 2017",
abstract = "Objective. To assess the uptake of the OMERACT-OARSI (Outcome Measures in Rheumatology- Osteoarthritis Research Society International) core outcome set (COS) domains in hip and/or knee osteoarthritis (OA) trials. Methods. There were 382 trials of hip and/or knee OA identified from the ClinicalTrial.gov registry from 1997 to 2017. Frequency of COS adoption was assessed by year and per 5-yearly phases. Results. COS adoption decreased from 61% between 1997 and 2001 to 38% between 2012 and 2016. Pain (95%) and physical function (86%) were most consistently adopted. Patient{\textquoteright}s global assessment (48%) was the principal missing domain. Conclusion. Limited adoption of the COS domains indicates that further consideration to improve uptake is required.",
author = "Smith, {Toby O.} and Michael Mansfield and Hawker, {Gillian A.} and Hunter, {David J.} and March, {Lyn M.} and Maarten Boers and Shea, {Beverley J.} and Robin Christensen and Francis Guillemin and Terwee, {Caroline B.} and Williamson, {Paula R.} and Roos, {Ewa M.} and Loeser, {Richard F.} and Schnitzer, {Thomas J.} and Margreet Kloppenburg and Tuhina Neogi and Ladel, {Christoph H.} and Gurdyal Kalsi and Ulrike Kaiser and Buttel, {Thomas W.} and Ashford, {Anne E.} and Ali Mobasheri and Arden, {Nigel K.} and Alan Tennant and Hochberg, {Marc C.} and {de Wit}, Maarten and Peter Tugwell and Conaghan, {Philip G.}",
year = "2019",
month = aug,
day = "1",
doi = "10.3899/jrheum.181066",
language = "English",
volume = "46",
pages = "976--980",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "8",
}